TAAR1’s Unseen Influence on Mental Disorders
A study at the Icahn School of Medicine has uncovered that asenapine, an antipsychotic medication, may work through the TAAR1 receptor, revealing crucial differences between human and rodent TAAR1. This discovery suggests new avenues for treating substance use and neuropsychiatric disorders and rethinking drug development strategies. Credit: SciTechDaily.comStudy sheds light on TAAR1, pointing to potential enhancement opportunities in drug development.Researchers at the Icahn School of Medicine at Mount Sinai have…